AiCuris Anti-infective Cures AG is a Wuppertal-based life science company specializing in the research and development of novel antiviral therapies for patients with compromised immune systems. The company markets its products primarily through licensing partnerships, such as with Merck & Co. for the drug Letermovir, or through its own development activities. The portfolio includes clinical candidates such as Pritelivir for the treatment of herpes simplex infections and AIC468 against BK virus infections. The company employs an average of 63 people and focuses on medical areas with high unmet needs.
Die Forschung und Entwicklung, die Vermarktung und Herstellung von Produkten, die Erbringung von Dienstleistungen und die sonstige industrielle Betätigung auf dem Gebiet der Gesundheit, insbesondere zur Entwicklung, Vermarktung und Herstellung neuer Medikamente und Therapien zur Verhinderung oder Behandlung von Infektionskrankheiten.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Wuppertal Local Court, HRB 31630 (as of 1 November 2026)
| Name | Type | City |
|---|---|---|
| Daniela Boshoven | Vorstand | Mülheim |
| Fredrik Johansson | Vorstand | Stockholm |
| Company | Location |
|---|---|
| Wuppertal | |
| Wuppertal | |
| Wuppertal |
Source: German Commercial Register (Handelsregister) Wuppertal Local Court, HRB 31630 (as of 1 November 2026)
| Date | Event Type | Event |
|---|---|---|
| 25.09.2023 | Satzung amended | Satzung |
| 16.06.2021 | Satzung amended | Satzung |
| 06.05.2021 | Company Name Change | AiCuris Anti-infective Cures AG |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 16.06.2021 | Capital Increase | +1 € | 15.000.001 € |
| 12.04.2021 | Share Capital Set | — | 15.000.000 € |
Source: German Commercial Register (Handelsregister) Wuppertal Local Court, HRB 31630 (as of 1 November 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2024 | — | — | €93,648,000 | — |
| 2023 | — | — | €75,995,000 | — |
| 2022 | €73,275,000 | — | €61,393 | — |
| 2021 | €40,734,000 | — | €39,718 | — |
| 2020 | €49,048,000 | €141,546,000 | €103,321,000 | — |
Sign in to download data
Source: German Commercial Register (Handelsregister) Wuppertal Local Court, HRB 31630 (as of 1 November 2026)
pfm medical gmbh
Köln · Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.
nal von minden GmbH
Moers · Herstellung von medizinischen und zahnmedizinischen Apparaten und Materialien a. n. g.
Ypsomed Distribution GmbH
Rheinfelden Baden · Erbringung von Dienstleistungen von medizinischen Laboratorien
